Skip to Content
Merck
All Photos(1)

Documents

856707C

Avanti

17:1 Lyso PE

1-(10Z-heptadecenoyl)-sn-glycero-3-phosphoethanolamine, chloroform

Synonym(s):

1-heptadecenoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine; PE(17:1(10Z)/0:0); 110699

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C22H44NO7P
CAS Number:
1246298-09-8
Molecular Weight:
465.56
UNSPSC Code:
12352211
NACRES:
NA.25

Assay

>99% (LPE; may contain up to 10% of the 2-LPE isomer, TLC)

form

liquid

packaging

pkg of 1 × 1 mL (856707C-5mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 856707C

concentration

5 mg/mL (856707C-5mg)

lipid type

cardiolipins
phospholipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

O[C@](COP([O-])(OCC[NH3+])=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O

Packaging

5 mL Clear Glass Sealed Ampule (856707C-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

also commonly purchased with this product

Product No.
Description
Pricing

SMB00506

1-Heptadecanoyl-rac-glycerol, ≥98% (HPLC)

830756P

17:0 PE, Avanti Research™ - A Croda Brand

850103P

17:1 Lyso PI, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol) (ammonium salt), powder

855676P

17:0 Lyso PC, Avanti Research™ - A Croda Brand

858127C

17:1 Lyso PG, 1-(10Z-heptadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

858141C

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), chloroform

858141P

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), powder

860517P

C17 Ceramide (d18:1/17:0), Avanti Research™ - A Croda Brand

860585P

17:0 SM (d18:1/17:0), Avanti Research™ - A Croda Brand 860585P, powder

860640P

Sphingosine (d17:1), Avanti Research™ - A Croda Brand 860640P, powder

860903P

17:0-17:1-17:0 D5 TG, Avanti Research™ - A Croda Brand 860903P, powder

LM1000

12:0-13:0 PC, Avanti Research™ - A Croda Brand LM1000, methanol solution

LM4100

cholesterol (D7), Avanti Research™ - A Croda Brand LM4100, methanol solution

Pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

Target Organs

Central nervous system, Liver,Kidney

WGK

WGK 3

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Peng Wu et al.
Chinese medicine, 15, 9-9 (2020-01-31)
Our previous clinical evidence suggested that the direct application of "Sanse powder" the main ingredient of "Yiceng" might represent an alternative treatment for knee osteoarthritis. However, the mechanism underlying its effect is poorly understood. In this study, we investigated the
Tsukasa Yagi et al.
Cancers, 12(1) (2020-01-01)
Ovarian cancer remains a highly lethal disease due to its late clinical presentation and lack of reliable early biomarkers. Protein-based diagnostic markers have presented limitations in identifying ovarian cancer. We tested the potential of phospholipids as markers of ovarian cancer
Biyu Hou et al.
Life sciences, 245, 117352-117352 (2020-02-02)
The depot-specific differences in lipidome of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reflect heterogeneity of white adipose tissue (WAT), which plays a central role in its distinct response to outside stimuli. However, the detailed lipidome of depot-specific
Jordon M Inloes et al.
Biochemistry, 57(39), 5759-5767 (2018-09-18)
Deleterious mutations in the serine hydrolase DDHD domain containing 1 (DDHD1) cause the SPG28 subtype of the neurological disease hereditary spastic paraplegia (HSP), which is characterized by axonal neuropathy and gait impairments. DDHD1 has been shown to display PLA1-type phospholipase

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service